<code id='74178235FA'></code><style id='74178235FA'></style>
    • <acronym id='74178235FA'></acronym>
      <center id='74178235FA'><center id='74178235FA'><tfoot id='74178235FA'></tfoot></center><abbr id='74178235FA'><dir id='74178235FA'><tfoot id='74178235FA'></tfoot><noframes id='74178235FA'>

    • <optgroup id='74178235FA'><strike id='74178235FA'><sup id='74178235FA'></sup></strike><code id='74178235FA'></code></optgroup>
        1. <b id='74178235FA'><label id='74178235FA'><select id='74178235FA'><dt id='74178235FA'><span id='74178235FA'></span></dt></select></label></b><u id='74178235FA'></u>
          <i id='74178235FA'><strike id='74178235FA'><tt id='74178235FA'><pre id='74178235FA'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:511
          Nasdaq
          Mark Lennihan/AP

          The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

          Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

          advertisement

          Acelyrin’s share price fell more than 60% in after-hours trading Monday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says
          Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

          1:35VIDEO:Catchuponthedevelopingstoriesmakingheadlines.STOCKIMAGE/GettyImagesAFordassemblyplantinCla

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Biden administration sends mixed signals on US soldier who crossed into North Korea

          3:54SouthKoreansoldierspatrolwhilehikersvisittheDMZPeaceTrailinthedemilitarizedzoneinGoseong,SouthKo